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OBJECTIVE—In this study, the effect of chronic hyperglycemia
on acute ligation-induced collateral vasodilation, on monocyte
chemotaxis, and on structural outward remodeling of collaterals
was investigated.
RESEARCH DESIGN AND METHODS—Femoral artery li-
gation was performed 8 weeks after alloxan or saline treat-
ment in New Zealand White rabbits. Angiography was
performed directly, 1 and 3 weeks after ligation. These angio-
graphic recordings were used to quantify number of collater-
als, lumen, and blood volume index. Reactive hyperemia
response was tested by intramuscular laser Doppler measure-
ments. Subsequently, blood was sampled from the aorta for
monocyte chemotaxis.
RESULTS—Ligation resulted in markedly lower acute collat-
eral vasodilation in diabetic compared with control rabbits.
Also, hyperemic vasodilatory response to local ischemia was
impaired in diabetic rabbits. This difference persisted at 1 and
3 weeks after ligation, with a lower number of visible collat-
erals. In addition, the collateral lumen was markedly lower in
diabetic rabbits after the maturation phase. Likewise, a re-
duced blood volume index in the region of growing collaterals
was observed in diabetic animals. The monocyte migration
toward vascular endothelial growth factor-A and monocyte
chemotactic protein-1 was strongly reduced in diabetic
rabbits.
CONCLUSIONS—This study demonstrates that chronic hyper-
glycemia negatively affects the different phases of arteriogenesis:
1) impaired shear induced vasodilatation; 2) impaired outward
collateral growth, reﬂected in the number of collaterals and
blood volume index; and 3) inhibition of monocyte chemotaxis.
Impairments were most evident in the acute phase of arteriogen-
esis. Therapies aimed at restoring acute collateral recruitment,
such as vasodilators, may be of interest to improve collateral
function in diabetes. Diabetes 57:2818–2823, 2008
I
ndividuals with diabetes have a substantially in-
creased risk (two- to fourfold) of developing isch-
emic cardiovascular events, with a poor prognosis
after these events (1), as illustrated by an increased
incidence of critical limb ischemia and lower-extremity
amputation in diabetic individuals (2,3). This poor clinical
outcome may be caused by impaired compensatory re-
sponses in the setting of acute or chronic ischemia in
diabetes, such as reduced vasodilation and delayed collat-
eral remodeling. Cardiovascular disease places a high
burden on economic reserves, medical capacities, and the
quality of life in diabetic patients, stressing the importance
of unraveling the underlying pathophysiological mecha-
nisms to improve current therapies (4).
Arteriogenesis, i.e., the acute recruitment (acute phase)
and subsequent outward remodeling (remodeling phase)
of collateral arteries, plays an important role in the adap-
tation to ﬂow obstruction and tissue ischemia (5,6). During
the occlusion of a conduit artery, often caused as a
complication of atherosclerosis, blood ﬂow is redirected
through adjacent preexisting collaterals. In contrast to
angiogenesis, which is initiated by ischemia, arteriogen-
esis occurs in regions of high-ﬂuid shear stress. Prolonged
elevated shear stress results in outward remodeling of a
preexisting collateral (7). Several studies have demon-
strated the importance of increased levels of endothelial
nitric oxide (NO) synthase (eNOS) mRNA and protein in
regions of increased shear stress (8,9). The increased NO
release in regions of increased shear stress leads to the
acute vasodilatory response of preexisting collaterals and
is critical for arteriogenesis (10). In diabetic subjects, this
response may be impaired because of endothelial dysfunc-
tion reﬂected by impaired NO release and/or vasodilatory
responses (11–13). Because vasodilation is the initial step
of outward remodeling, impairments in this phase might
be fundamental for impaired outward remodeling. Under
conditions of prolonged increased shear stress, structural
outward remodeling occurs and involves attraction and
adherence of monocytes and the degradation of the
extracellular matrix (14). In both diabetic animals and
diabetic patients, impaired attraction of circulating cells
(15,16) and impaired collagenolysis have been described
previously (17,18).
In healthy animal models, therapeutic arteriogenesis by
means of growth factors has been demonstrated to stim-
ulate outward remodeling of collateral vessels (19–22).
However, therapeutic application of these growth factors
showed limited success in clinical phase II studies, which
can in part be attributed to comorbidities in the patient
population, such as diabetes (23). Although previous stud-
ies have demonstrated that outward remodeling may be
impaired by hyperglycemia (18,24–26), little is known
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arteriogenesis process. We hypothesize that the diabetic
state may induce signiﬁcant disturbances in collateral
development by impairment of both the acute and struc-
tural remodeling phase of arteriogenesis. The rabbit isch-
emic hind limb model has been used extensively in
arteriogenesis research. In recent years, we have adapted
this model to study collateral artery growth longitudinally
in the same animal (27). The aim of the present study was
to investigate the effect of experimental diabetes on both
the acute and remodeling phases of collateral develop-
ment in the ischemia hind limb model and the role of
monocyte chemotaxis.
RESEARCH DESIGN AND METHODS
The present study was performed with the approval of the Animal Experi-
mental Committee of our institution. Thirty-one New Zealand White rabbits
were included and randomly assigned to receive either alloxan or saline
injection (same volume as alloxan). Alloxan (110 mg/kg) was injected into the
lateral ear vein to induce type 1–like diabetes in the rabbit. To prevent initial
hypoglycemia, 10 ml 5% glucose i.v. was injected after alloxan administration,
and drinking water with 10% glucose was supplemented for the ﬁrst 24 h.
Weight and blood glucose levels were determined on a weekly basis. Rabbits
with blood glucose levels 10 mmol/l (n  9) were excluded for further
investigation. In a subset of these alloxan-treated rabbits (n  4), blood
glucose levels did not change and served as controls for alloxan side effects.
Eight weeks after saline or alloxan injection, unilateral femoral artery ligation
was performed in both diabetic (n  10) and control rabbits (n  12). During
the procedure, the rabbits were ventilated with isoﬂurane (2–3%). The left
femoral artery was ligated (day 0) under sterile conditions by placing two
ligations (2 cm apart) distal to the branches of the circumﬂex artery and the
deep femoral artery. The occlusion of a conductance artery causes blood ﬂow
redistribution through interconnecting (preexisting) arterioles, which causes
functional changes in the endothelium through activation of the shear
stress–responsive element (28). Buprenorphine was given intramuscularly as
postoperative analgesia and was continued twice a day for 2 days. During the
3-week follow-up period, no pressure sores or signs of gangrene were
observed in the ligated limbs of either control or diabetic rabbits. Animals
were killed by lethal bleeding.
X-ray angiography. Angiograms were performed in the same animal imme-
diately (within 30 min), 1 week, and 3 weeks after femoral artery ligation to
monitor the remodeling of collaterals over time. Coronal X-ray angiography
(XRA) series (12 frames per second) were obtained using a portable X-ray
system (BV Pulsera; Philips Medical Systems, Best, the Netherlands) (in-plane
resolution 300  300 m; ﬁeld of view 220  220 mm; operated at tube voltage
72 kV). Bolus injections of a nonionic iodine contrast agent (Omnipaque;
Amersham Health, Eindhoven, the Netherlands) (5 ml/s; 240 mg iodine/ml; 1.6
ml/kg body wt) were given through a catheter (4F) inserted via the carotid
artery and placed 2–3 cm proximal to the abdominal aorta bifurcation. XRA
ﬁlms were digitally stored for ofﬂine analysis. The number of collaterals was
counted by two independent observers as deﬁned by Longland (29), which
requires identiﬁcation of the stem, midzone, and reentry zone. Angiographi-
cally visible collaterals were derived from three main vessels: the circumﬂex
artery, the deep femoral artery, and the internal iliac artery. For the 3-week
time point, collaterals were categorized as smaller or larger than 600 m
(pixel size 300 m) in diameter.
Quantitative subtraction angiography. To address the importance of the
luminal volume of collateral arteries, we developed and applied quantitative
subtraction angiography. This method enables automated and observer-
independent collateral artery growth quantiﬁcation. To this end, computa-
tional software was developed in MATLAB (The Math Works, Natick, MA).
Early precontrast frames of the angiographic time series, frame numbers 3–12
before contrast injection, were averaged to provide a noise-suppressed
precontrast mask image (Ipre) on which all anatomic structures were depicted
except the blood vessels. The frame with maximal contrast intensity of the
collateral arteries was deﬁned. Five frames above and below this maximal
intensity frame were averaged to provide a noise-suppressed maximal con-
trast image (Imax). For signal analysis, the quantitative description by Bush-
berg et al. (30) was used. On the pertaining logarithmic subtraction images
(Isub), the region of interest was manually drawn based on predeﬁned
landmarks in the adductor magnus muscle of the ligated limb in the direct
surrounding of the occlusion. This is the site of collateral anastomoses derived
from the deep femoral artery and the internal iliac artery, as depicted in Fig. 1. In
this region of interest, the number of enhanced pixels (above noise level) due
to collateral ﬁlling were quantiﬁed directly, 1 and 3 weeks after ligation. In
addition, the signal intensities of the pixels in the subtraction angiogram were
normalized to the maximal absolute signal intensity in the aorta to provide a
measure of the blood volume as function of signal intensity relative to the
aorta enhancement. The blood volume index is then deﬁned as the sum of
pixel intensities (Isub above noise level), normalized to the maximal aortic
signal intensity in the subtraction images in the region of collateral growth.
Reactive hyperemia response was tested 3 weeks after ligation in a subset
of healthy (n  5) and diabetic (n  5) rabbits with intramuscular laser
Doppler in the gastrocnemius muscle. An intramuscular laser Doppler needle
probe was positioned in m. gastrocnemius of the right limb, as described
previously (31). Temperature and blood pressure were kept constant during
the measurement period. Baseline laser Doppler measurements were started
after a 20-min stabilization period. Subsequently, a vascular clamp was placed
on the iliac artery and the iliac vein. After 10 min, the clamp was released, and
the reactive hyperemia response in terms of peak perfusion and time to peak
could be assessed.
Monocyte chemotaxis analysis was performed ex vivo as previously
described (16) 3 weeks after ligation. Brieﬂy, blood-derived monocytes were
isolated from 65 ml whole blood obtained in heparinized tubes by arterial
puncture just above the bifurcation of the iliac artery. Blood was layered onto
Histopaque-1077 (Sigma), and the mononuclear interface was collected.
FIG. 1. Example of an X-ray angiogram and the region of interest (circle) in the ligated limb (A) and post-subtraction angiograms (B) 3 weeks
after ligation.
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a further gradient centrifugation. The collected monocytes were washed in
PBS and resuspended in Dulbecco’s modiﬁed Eagle’s medium (Biochrom).
The number of isolated monocytes was counted by light microscopy using a
Neubauer chamber. The vitality of the isolated monocytes was assessed by
trypan blue exclusion; routinely, this was 72%. Monocyte chemotaxis was
quantiﬁed using a modiﬁed 48-well Boyden chamber (Nuclepore). The che-
moattractants vascular endothelial growth factor-A (VEGF-A; 1 ng/ml) (Reli-
atech), monocyte chemotactic protein-1 (MCP-1; 30 ng/ml) (Reliatech), or
formylMetLeuPhe (fMLP) (10
8 mol/l) (Sigma) were added to the lower
chamber. The monocyte suspension (5  10
5 cells/ml) was added to the upper
chamber, which was separated from the lower chamber by a 5-m-pore size
polycarbonate membrane (Nuclepore). After incubation for 1.5 h at 37°C in a
5% CO2 atmosphere, adherent cells on the ﬁlter membrane were ﬁxed in 99%
ethanol for 10 min and stained using Giemsa dye. The upper side of the
polycarbonate membrane was scraped to remove the nonmigrated cells. The
migrated cells adhering to the lower side of the membrane were counted in
ﬁve high-power ﬁelds and in three different wells using light microscopy.
Capillary-to-ﬁber ratio. Immediately after the lethal bleeding, 3 weeks after
ligation, the tibialis and soleus muscle were dissected from the lower limb,
from both the ligated and the contralateral side. Cryosections (10 m), cut
perpendicular to the muscle ﬁber direction, were stained using nitroblue
tetrazolium/5 bromo-4-chloro-3-indolylphosphate-p-toluidine salt (Gibco,
Grand Island, NY) of alkaline phosphatase in endothelial cells. The ratio of
capillary to ﬁber was scored in three randomly selected optic ﬁelds in each
muscle section.
Statistical analysis. All results are expressed as median and interquartile
range, except data from subtraction angiography and the capillary-to-ﬁber
ratio, which are expressed as mean and SE. Differences in the glucose levels,
total number of collaterals, collateral lumen, blood volume index, and
monocyte migration function of control and diabetic rabbits were compared
by the Mann-Whitney two-tailed test. The level of statistical signiﬁcance was
set at P  0.05.
RESULTS
Animal model
Glucose levels in rabbits that received alloxan increased
after 2 days, reached a steady state within 1 week, and
remained elevated until the rabbits were killed. Glucose
levels were signiﬁcantly increased in the diabetic rabbits
compared with the controls: 23.2 (17.7–30.3) and 6.55
(6.2–7.6) mmol/l, respectively. Body weight at the end of
the study was not different between the diabetic and
control animals: 3.2 (3–3.5) and 3.1 (3.0–3.2) kg, respec-
tively. Rabbits treated with alloxan without any effects on
glucose levels showed responses similar to the untreated
rabbits (data not shown).
XRA
Number of collaterals. Immediately after ligation (0
weeks), no collateral recruitment in diabetic rabbits was
observed (Fig. 2), whereas in healthy animals, 6.5 (5–7.75;
P  0.0001) collaterals were counted. One week after
ligation, the number of collaterals was 30% lower in
diabetic than control rabbits: 10 (8.5–11.5) versus 13
(10.25–14.0; P  0.058) collaterals, respectively. Three
weeks after ligation, a signiﬁcantly lower number of
collaterals was observed in diabetic rabbits, 10 (9.5–12.0),
compared with controls, 13.5 (11.25–14; P  0.026).
Size of collaterals. In diabetic animals, the size of the
collaterals was smaller than in controls (Fig. 3; data are
expressed as percentage of total number of collaterals).
Three weeks after ligation, only 12.5% (0–26) of collat-
erals in diabetic animals was 600 m. In the control
group, this percentage was markedly higher, 43% (30–
50) (P  0.002).
Quantitative subtraction angiography. Subtraction
angiography in the region of remodeling collaterals
showed less enhanced pixels in the tissues of diabetic
rabbits than controls, suggesting a reduction in blood
volume (Fig. 4). In the control group, the number of
enhanced pixels increased signiﬁcantly within 1 week,
in contrast to the diabetic rabbits, which showed a
signiﬁcant increase only at 3 weeks after ligation. Dia-
betic rabbits had a markedly lower blood volume index
than controls; values were 57% lower directly after
ligation (P  0.030), 61% after 1 week (P  0.004), and
45% after 3 weeks (P  0.045).
Reactive hyperemia. Impaired vasodilatory response in
diabetic rabbits was conﬁrmed by reactive hyperemia
experiments, performed in a subset of rabbits (four con-
trols and four diabetic rabbits). The peak perfusion, based
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FIG. 2. Number of collaterals in the left limb immediately, 1 week, and
3 weeks after ligation. The P values between diabetic rabbits (u) and
controls () are presented at different time points. Values are repre-
sented as median (bold line), 25–75 percentiles (box), and 5–95
percentiles (whiskers).
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FIG. 3. Percentage of collaterals with a lumen >600 m in the left limb
3 weeks after ligation. The diabetic rabbits (u) had a signiﬁcantly
lower percentage of collaterals >600 m than the control rabbits ().
Values are represented as median (bold line), 25–75 percentiles (box),
and 5–95 percentiles (whiskers).
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within2si ncontrol animals and was completely absent in
diabetic rabbits.
Monocyte chemotaxis. In Fig. 5, the migratory response
of monocytes toward two different growth factors
(VEGF-A and MCP-1) and the chemoattractant peptide
(fMLP) as a positive control are shown (data are ex-
pressed as a percentage of unstimulated monocytes). In
control animals, VEGF-A and MCP-1 induced a strong
chemotactic response in monocytes. VEGF-A–induced mi-
gration of monocytes was twofold lower in diabetic rab-
bits compared with controls (P  0.019). The same was
observed for MCP-1 stimulation (P  0.028). No difference
between controls and diabetic rabbits was observed in the
fMLP-induced migratory response.
Capillary-to-ﬁber ratio. In the contralateral limb, cap-
illary-to-ﬁber ratios were higher in the soleus muscle than
in the anterior tibialis muscle: 2.57  0.14 and 1.98  0.13
(mean ratio  SE), respectively. Hyperglycemia did not
affect the capillary-to-ﬁber ratios in the tibialis and soleus
muscle in the contralateral limb. Three weeks after liga-
tion, the ratios were similar to baseline levels, indicating
that neither ligation nor hyperglycemia had an effect on
capillary-to-ﬁber ratio.
DISCUSSION
Preexisting collaterals provide an alternative way of blood
supply to a region distal to an arterial occlusion (32).
Progressive occlusion of a conductance artery due to
atherosclerosis results in sustained blood ﬂow redistribu-
tion through these collaterals, thereby triggering these
vessels to increase their lumen (acute vasodilation) and
express adhesion molecules and attracting factors that
ultimately lead to structural outward remodeling of the
preexisting collateral artery (19,33). This study demon-
strates that chronic hyperglycemia negatively affects the
acute phase of the arteriogenic process. Both shear-
induced vasodilatation and monocyte migration were im-
paired in diabetic rabbits. In addition, we observed
impaired outward collateral growth in diabetic rabbits, as
reﬂected by the number of collaterals and the blood
volume index in the region of remodeling collaterals
compared with nondiabetic animals.
The most prominent differences between healthy and
diabetic rabbits were observed in the acute phase of the
arteriogenic process. Angiography showed a rapid recruit-
ment of preexisting collateral arteries directly after liga-
tion in healthy rabbits in contrast to the diabetic rabbits. In
addition, the postocclusive reactive hyperemic vasodila-
tory response was impaired in our diabetic animals. In the
contralateral limb, preexisting collaterals were not visible
in either the diabetic or the nondiabetic animals. These
data concur with earlier studies that showed that impaired
ﬂow mediated vasodilation or postocclusive reactive hy-
peremic vasodilatory response in diabetes (34,35). The
defect in collateral recruitment could also have been
caused by an impaired runoff secondary to a decrease in
capillary-to-ﬁber ratio. However, we did not observe an
effect of chronic hyperglycemia on baseline capillary-to-
ﬁber ratio nor were there any differences in this ratio 3
weeks after ligation. The current study is, to our knowl-
edge, one of the ﬁrst to show an impaired immediate
recruitment of preexisting collaterals in diabetes. Both
shear-mediated vasodilation and reactive hyperemia (in
part) are mediated by NO. Because shear stress–induced
vasodilation is postulated to be the initiation step of
arteriogenesis, loss of this vasodilatory response might
contribute to the poorer outcome after occlusion of a
conduit artery in the case of diabetes. Our assumption that
impaired recruitment has detrimental effects on collateral
growth is conﬁrmed by the work of Yu et al. (36) who
demonstrated impaired contraction-stimulated hyperemia
and impaired arteriogenesis in an eNOS knockout mouse
model. One of the main pathways responsible for vasodi-
lation after high-ﬂuid shear stress is the Akt-eNOS path-
way (37,38). An explanation for the impaired vasodilation
response in preexisting collaterals to increased shear
stress in diabetic rabbits, as observed in this study, might
be the impaired eNOS activation and NO generation (39)
by mechanisms such as inhibition of phosphorylation of
PI3K and Akt and peroxynitrite generation by hyperglyce-
mia (40). Besides the adverse effects of diabetes on
vasomotor tone regulation, mechanotransduction and ex-
pression of vasoactive proteins might also be affected by
hyperglycemia. Further studies are necessary to elucidate
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FIG. 4. The blood volume index, deﬁned as the sum of pixel intensities
in a predeﬁned region of interest, in the left limb immediately, 1 week,
and 3 weeks after ligation. Blood volume index was persistently lower
in the diabetic rabbits (f) compared with the controls (). Data are
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FIG. 5. Chemotactic response of monocytes toward 10 ng/ml VEGF-A,
10 ng/ml MCP-1, and 10
8 mol/l fMLP gradient. Monocytes were iso-
lated from either diabetic (u) or control () rabbits. Data are pre-
sented as median (bold line), 25–75 percentiles (box), and 5–95
percentiles (whiskers).
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stress sensing in preexisting collaterals that results in
impaired outward remodeling.
Sustained shear stress leads to activation of the collat-
eral endothelial cells. Subsequently, monocyte recruitment
and adhesion to activated endothelium occur. The mi-
grated monocytes mature into macrophages and release
different growth factors important in outward remodeling
of the collateral. In this study, the impaired migratory
response of monocytes toward VEGF-A and MCP-1 gradi-
ent in diabetic rabbits conﬁrms the results described
previously in clinical studies (16). The inhibitory effects of
hyperglycemia on monocyte function might also be ex-
plained by an impaired signaling downstream the VEGF
receptor (41). Also for the migration toward VEGF, im-
paired eNOS signaling has been shown in endothelial
progenitor cells derived from diabetic patients (15).
Previous studies on arteriogenesis focused on postmor-
tem angiograms and/or hemodynamic measurements. We
introduced the technique of serially obtained in vivo
angiograms (27). Both number and lumen of collaterals
were increased directly after ligation up to 21 days after
ligation in control rabbits, but this process was signiﬁ-
cantly impaired in diabetic rabbits. These ﬁndings agree
with a previous report showing a signiﬁcantly lower
angiographic score in the diabetic ischemic mice model
(18,26).
The quantiﬁcation of the collateral lumen and grading of
collateral ﬁlling based on the commonly used Rentrop
classiﬁcation is subjective. We have applied subtraction
angiography to quantify the blood volume index in the
region of collateral growth. Advantages of our quantitative
subtraction angiography are the operator-independent
analyses and the quantitative values. The disadvantage of
this method is that no absolute blood volume or ﬂow
values are derived. For several reasons we preferred this
method above other blood ﬂow analyses. First, blood
volume index is a measure of collateral-dependent full-
thickness limb perfusion, and unlike laser Doppler imag-
ing, it is not limited to superﬁcial tissues. It is assumed that
superﬁcial and deep perfusion are correlated and recovery
of skin perfusion in diabetic ischemic mice is signiﬁcantly
impaired (18,26). However, this correlation has never been
tested. Second, the angiographic method allows longitudi-
nal follow-up, which is a major advantage over the accu-
rate but destructive methods required for microspheres or
collateral conductance measurements. On our subtraction
angiograms, the blood volume index was derived from the
ﬁrst pass of the contrast medium, which is directly related
to the blood ﬂow. The subtraction analysis showed a
signiﬁcant difference in blood volume index between
diabetic and control rabbits directly after ligation (acute
phase) and during the remodeling phase of arteriogenesis.
In summary, we conclude that the number of collaterals
and the blood volume index are important contributing
factors to the blood perfusion recovery distal to the
occlusion and are valuable measures to quantify the level
of collateral growth.
The current study results emphasize the importance of
shear-induced vasodilation of preexisting collaterals in
arteriogenesis. If we seek to restore the impaired collat-
eral remodeling in diabetic subjects, we hypothesize that
improvement of shear-induced collateral recruitment by
suitable vasodilators might show beneﬁt. The importance
of NO in the arteriogenic process has already been de-
scribed by Yang et al. (10). In addition, it has been
described that NO is critical for effective therapeutic
arteriogenesis achieved by delivery of exogenous growth
factors (e.g., VEGF and ﬁbroblast growth factor-2) (42).
Future studies should give us a better understanding of the
impairment in the PKA/Akt-eNOS pathway in diabetic
subjects. Selection of a vasodilator candidate that by-
passes the impaired signaling level might open new meth-
ods of therapeutic arteriogenesis in diabetic patients by
restoring the impaired recruitment of collaterals but also
monocyte chemotaxis and growth factor signaling.
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